Hervé Perrier

2.6k total citations
63 papers, 1.3k citations indexed

About

Hervé Perrier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Hervé Perrier has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Hepatology. Recurrent topics in Hervé Perrier's work include Colorectal Cancer Treatments and Studies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Gastric Cancer Management and Outcomes (11 papers). Hervé Perrier is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Gastric Cancer Management and Outcomes (11 papers). Hervé Perrier collaborates with scholars based in France, United States and Switzerland. Hervé Perrier's co-authors include Marc Giovannini, J. F. Seitz, G. Monges, Jean‐Luc Raoul, Marc Bourlière, Xavier Adhoute, Paul Castellani, Guillaume Pénaranda, Laëtitia Dahan and Jean‐Robert Delpéro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Hervé Perrier

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hervé Perrier France	18	627	522	504	377	352	63	1.3k
Jae‐Jun Shim South Korea	22	393 0.6×	334 0.6×	403 0.8×	316 0.8×	463 1.3×	75	1.2k
Judy Wyatt United Kingdom	18	391 0.6×	672 1.3×	341 0.7×	448 1.2×	283 0.8×	49	1.2k
Ilaria Panzini Italy	17	286 0.5×	317 0.6×	299 0.6×	298 0.8×	169 0.5×	35	1.0k
Yolanda Quijano Spain	21	834 1.3×	814 1.6×	462 0.9×	197 0.5×	190 0.5×	118	1.4k
Paolo Magistri Italy	20	444 0.7×	709 1.4×	464 0.9×	443 1.2×	167 0.5×	101	1.2k
Jérôme Desrame France	20	762 1.2×	601 1.2×	596 1.2×	119 0.3×	180 0.5×	106	1.4k
Ameet Dhar United Kingdom	14	570 0.9×	487 0.9×	223 0.4×	390 1.0×	622 1.8×	25	1.2k
Richard Sturgess United Kingdom	20	450 0.7×	1.0k 1.9×	712 1.4×	366 1.0×	501 1.4×	69	1.9k
Takafumi Abo Japan	21	476 0.8×	764 1.5×	485 1.0×	588 1.6×	336 1.0×	101	1.4k
Masatoshi Isogai Japan	18	463 0.7×	759 1.5×	445 0.9×	374 1.0×	278 0.8×	109	1.2k

Countries citing papers authored by Hervé Perrier

Since Specialization

Citations

This map shows the geographic impact of Hervé Perrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Perrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Perrier more than expected).

Fields of papers citing papers by Hervé Perrier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Perrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Perrier. The network helps show where Hervé Perrier may publish in the future.

Co-authorship network of co-authors of Hervé Perrier

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Perrier. A scholar is included among the top collaborators of Hervé Perrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Perrier. Hervé Perrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bourgeois, Denis, Daouda Faye, Marta Mazur, et al.. (2025). Interdental Brushing and Obstetrical Outcomes in Nulliparous Pregnant Women: Insights From a Cluster Randomised Controlled Trial. Journal Of Clinical Periodontology. 53(3). 436–444.

Abdelghani, Méher Ben, et al.. (2024). 507O Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial. Annals of Oncology. 35. S431–S431. 2 indexed citations

Tougeron, David, JF Émile, Emilie Barbier, et al.. (2024). 502O Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial. Annals of Oncology. 35. S428–S428.

Tougeron, David, Jean‐François Emile, Emilie Barbier, et al.. (2024). LBA1 Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trial. Annals of Oncology. 35. S212–S212. 1 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Thomas Wolf, et al.. (2023). Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations

Clément, Céline, et al.. (2023). Efficacy of Sonic-Powered and Manual Toothbrushes on Plaque-Induced Gingivitis in Pregnant Women: A Randomized Controlled Trial. Methods and Protocols. 6(5). 99–99. 1 indexed citations

Rusquec, Pauline du, Rosine Guimbaud, Karine Le Malicot, et al.. (2023). Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens. ESMO Open. 8(4). 101616–101616. 1 indexed citations

Adhoute, Xavier, Laurent Mineur, Guillaume Pénaranda, et al.. (2022). Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching. World Journal of Gastrointestinal Oncology. 14(8). 1510–1527. 7 indexed citations

Adhoute, Xavier, Rodolphe Anty, P. Chevallier, et al.. (2021). Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results. World Journal of Clinical Cases. 9(18). 4559–4572. 3 indexed citations

10.

Carrouel, Florence, Martine Valette, Émilie Gadéa, et al.. (2021). Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial. Clinical Microbiology and Infection. 27(10). 1494–1501. 32 indexed citations

11.

Perrier, Hervé, Marine Lefèvre, Christophe Louvet, et al.. (2020). Drastic Reduction of Turnaround Time After Implementation of a Fully Automated Assay for RAS-BRAF Mutations in Colorectal Cancer: A Pilot Prospective Study in Real-life Conditions. Pathology & Oncology Research. 26(4). 2469–2473. 2 indexed citations

12.

Phelip, Jean–Marc, Jérôme Desrame, Julien Edeline, et al.. (2020). 52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial. Annals of Oncology. 31. S260–S261. 11 indexed citations

13.

Raoul, Jean‐Luc, Xavier Adhoute, Guillaume Pénaranda, et al.. (2019). Sorafenib: Experience and Better Management of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis. Liver Cancer. 8(6). 457–467. 45 indexed citations

14.

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2017). Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World Journal of Gastroenterology. 23(14). 2545–2545. 20 indexed citations

15.

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process. Journal of Hepatology. 62(4). 855–862. 117 indexed citations

16.

Gonçalvès, Anthony, Marine Gilabert, E. François, et al.. (2012). BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer. Annals of Oncology. 23(11). 2799–2805. 176 indexed citations

17.

Sibon, David, Giovanna Cannas, Thomas Prébet, et al.. (2011). Lenalidomide in lower‐risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis‐stimulating agents. British Journal of Haematology. 156(5). 619–625. 29 indexed citations

18.

Bourlière, Marc, Michel Rotily, V. Guagliardo, et al.. (2002). Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. Journal of Viral Hepatitis. 9(1). 62–70. 86 indexed citations

19.

Seitz, Jean‐François, et al.. (1998). 5-Fluorouracil, High-Dose Folinic Acid and Mitomycin C Combination Chemotherapy in Previously Treated Patients with Advanced Colorectal Carcinoma. Journal of Chemotherapy. 10(3). 258–265. 21 indexed citations

20.

Giovannini, Marc, et al.. (1995). Fine-Needle Aspiration Cytology Guided by Endoscopic Ultrasonography: Results in 141 Patients. Endoscopy. 27(2). 171–177. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact